Stock TRILC TURK ILAC VE SERUM SANAYI ANONIM SIRKETI
Add to a list
To use this feature you must be a member
Log inSign up

Company Turk Ilac Ve Serum Sanayi Anonim Sirketi

Equities

TRILC

TRETRLC00022

Pharmaceuticals

Market Closed - Borsa Istanbul
Other stock markets
 08:39:24 15/05/2024 pm IST 		5-day change 1st Jan Change
30.98 TRY -0.13% Intraday chart for Turk Ilac Ve Serum Sanayi Anonim Sirketi +15.86% +171.04%
04/04 Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical company. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The company also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.

Number of employees: 439

Sales per Business

TRY in Million2022Weight2023Weight Delta
Serum
87.6 %
529 63.5 % 1,676 87.6 % +216.65%
Dialysis Materials
5.6 %
71 8.6 % 107 5.6 % +49.75%
Tablet Medicine
3.4 %
41 5.0 % 65 3.4 % +56.93%
Foreign Sales
3.3 %
51 6.1 % 63 3.3 % +23.68%
Other
0.2 %
27 3.3 % 4 0.2 % -83.84%
Sales Return
-0.1 %
-12 -1.4 % -3 -0.1 % -78.47%
Vaccine
0.0 %
126 15.1 % 1 0.0 % -99.55%
Sales Discount
0.0 %
-1 -0.1 % 0 0.0 % -98.87%

Sales per region

TRY in Million2022Weight2023Weight Delta
Turkey
100.0 %
833 100.0 % 1,913 100.0 % +129.56%

Managers

Managers TitleAgeSince
Yunus Emre Battal CEO
 Chief Executive Officer - 26/21/26
Yakup Karakus BRD
 Director/Board Member - 01/20/01
Atilla Akgünlü IRC
 Investor Relations Contact - 01/22/01

Members of the board

Members of the board TitleAgeSince
Mehmet Berat Battal FOU
 Founder - 04/10/04
Yunus Emre Battal CEO
 Chief Executive Officer - 26/21/26
Onur Örsel BRD
 Director/Board Member 42 01/20/01
Yakup Karakus BRD
 Director/Board Member - 01/20/01
Volkan Sapmaz BRD
 Director/Board Member - 26/21/26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 161,805,000 96,863,714 ( 59.86 %) 0 59.86 %

Shareholders

NameEquities%Valuation
Mehmet Berat Battal
40.14 %
64,941,286 40.14 % 50 M ₺
Dimensional Fund Advisors Ltd.
0.0252 %
40,828 0.0252 % 31 274 ₺
AK Asset Management AS
0.0216 %
35,000 0.0216 % 26 810 ₺
DFA Australia Ltd.
0.000200 %
323 0.000200 % 247 ₺

Company contact information

Türk Ilaç ve Serum Sanayi AS

Bügdüz Mahallesi Enver Pasa Caddesi, 8

06750, Ankara

+90 312 837 67 67

http://www.turkilac.com.tr
address Turk Ilac Ve Serum Sanayi Anonim Sirketi(TRILC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
TURK ILAC VE SERUM SANAYI ANONIM SIRKETI Stock Turk Ilac Ve Serum Sanayi Anonim Sirketi
+171.04% 16Cr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 36TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+5.69% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 24TCr
NOVARTIS AG Stock Novartis AG
+9.93% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 20TCr
AMGEN INC. Stock Amgen Inc.
+10.77% 17TCr
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TRILC Stock
  4. Company Turk Ilac Ve Serum Sanayi Anonim Sirketi
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW